Hostname: page-component-848d4c4894-m9kch Total loading time: 0 Render date: 2024-05-14T21:57:18.868Z Has data issue: false hasContentIssue false
  • English
  • Français

Aspects of Stroke Imaging

Published online by Cambridge University Press:  24 February 2017

Alastair Buchan
Alastair Buchan*
Affiliation:
Calgary, Alberta
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Canadian Journal of Neurological Sciences , Volume 28 , Issue 2 , May 2001 , pp. 99 - 100
Copyright
Copyright © The Canadian Journal of Neurological 2001

References

REFERENCES

1. Silver, B, Demaerschalk, B, Merino, JG, et al. Improved outcomes in stroke thrombolysis with pre-specified imaging criteria. Can J Neurol Sci 2001;28:113–119.Google Scholar
2. National Institute of Neurological Disorders and Stroke re-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581–1587.Google Scholar
3. Hacke, W, Kaste, M, Fieschi, C, et al, for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274:1017–1025.Google Scholar
4. Hacke, W, Kaste, M, Fieschi, C, et al. Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Lancet 1998; 352:1245–1251.CrossRefGoogle Scholar
5. Hill, MD, Barber, PA, Demchuk, AM, Buchan, AM. Time is brain: post-marketing experience with alteplase (tPA) for acute ischemic stroke. Today’s Therapeutic Trends 2000; 18:285–305.Google Scholar
6. Demchuk, AM, Morgenstern, LB, Krieger, D, et al. Is baseline serum glucose a predictor of hemorrhage after rtPA therapy in acute stroke? Stroke 1999; 30: 34–39.Google Scholar
7. Von Kummer, R, Allen, KL, Holle, R, et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 1997; 205:327–333.CrossRefGoogle ScholarPubMed
8. Schriger, D, Kalafut, M, Starkman, S, et al. Cranial computed tomography interpretation in acute stroke. Physicians’ accuracy in determining eligibility for thrombolytic therapy. JAMA 1998; 279:1293–1297.Google Scholar
9. Grotta, J, Chiu, D, Lu, M, et al. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA. Stroke 1999; 30:1528–1533.Google Scholar
10. Wardlaw, JM, Dorman, PJ, Lewis, SC, Sandercock, PAG. Can stroke physicians and neurologists identify signs of early cerebral infarction on CT? J Neurol Neurosurg Psychiatry 1999; 67:651–653.Google Scholar
11. Barber, PA, Demchuk, AM, et al, for the ASPECTS Study Group. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet 2000; 355:1670–1674.Google Scholar
12. Clark, WW, Wissman, S, Albers, GW, et al. The Atlantis Study: recombinant tissue plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. JAMA 1999;282:2019–2026.Google Scholar
13. Baird, AE, Warach, S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab 1998; 18:583–609.CrossRefGoogle ScholarPubMed
14. Barber, PA, Zhang, J, Demchuk, AM, Hill, MD, et al. Why stroke patients don't receive tPA? An analysis of patient eligibility. Neurology 2001;56:1015–1029.Google Scholar
15. Baron, JC, Von Kummer, R, Del Zoppo, GJ. Treatment of acute ischemic stroke: challenging the concept of a rigid and universal time window. Stroke 1995;26:2219–2221.Google Scholar